The amyloid hypothesis on trial
nature.com
nature.com
It's not simply that drugs have failed time and again for Alzheimers. It's a very hard disease to come up with a treatment for. Here are some challenges:
1) It's a hard disease to detect in the earliest stages, where preventative/slowing drugs would have the most effect. If your drug slows decline by 30% but you start using the drug after 60% of the decline has already occurred, your effect size will be much smaller.
2) The blood-brain-barrier is a strong obstacle in our anatomy that prevents the passage of many potentially useful small or large molecules from general circulation into the brain.
3) Our early-stage disease models, things from petri dishes to mice, are less effective for choosing winners in this disease in particular. Maybe due to the complexity of the human neurology, though TBH I'm not sure why this is.
4) Even if you reduce beta-amyloid or other biomarkers, if you can't slow the disease progression/symptoms, then why is your drug useful? It's much harder to provide the slowing or reduction of cognitive decline than it is to simply clean up the beta-amyloid plaques. 4) is a specific case of the general use of "biomarkers" or "surrogate endpoints" - you need to measure SOME outcome, it's hard to do for cognitive diseases, so you find something measurable and look at that, though the linkage to symptoms is not totally clear in many cases.
So all of our models are pretty artificial. And we build our rat models off of our disease assumptions, like injecting rats with beta amyloid because we assume that's the primay cause of brain dysfunction.
But it's looking more and more like that's wrong and beta amyloid is not the central player in Alzheimer's but just one of many. With Tau/insulin resistance/herpes/glial dysfunction/neuroinflammation playing important rules as well.
[1] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496102/ [2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3720142/
https://medium.com/@InfinoMe/cholesterol-have-we-shot-the-me...
and subcosmos's comment "Right on the heals of the recent publication that shows that beta-amyloid in the brain specifically wraps around HerpesViral particles in order to prevent them from spreading!" (1st comment on the above).
There seems evidence the amyloid is a body defence against viral infection, mostly herpes 6&7.
This supports the OP: amyloid may not be the culprit. In a phase 3 trial, the drug may not pan out.
source: nyti.ms/2JWjznT
Also, this submission was in response to https://news.ycombinator.com/item?id=17617054.
> The results suggest that memory loss may be reversed and improvement sustained with the therapeutic program, but Bredesen cautioned that the results need to be replicated.
> “The current, anecdotal results require a larger trial, not only to confirm or refute the results reported here, but also to address key questions raised, such as the degree of improvement that can be achieved routinely, how late in the course of cognitive decline reversal can be effected, whether such an approach may be effective in patients with familial Alzheimer’s disease, and last, how long improvement can be sustained,” he said.
From http://newsroom.ucla.edu/releases/memory-loss-associated-wit...
There is a new study with ~100 patients but is is not yet finished.
1. https://www.ted.com/talks/lisa_genova_what_you_can_do_to_pre...
Is it possible that there is a natural cure for Alzheimer's? Given we don't know the cause yet, sure it is possible. But one study with 10 people is not enough evidence to claim there is one. If you simply said "hey I found this interesting, published study that suggests there may be a natural treatment", then you probably wouldn't have been down voted to hell. Instead you asserted that there is a natural treatment with very little evidence.
1. Patients didn't actually have Alzheimer's. Given the only definitive test for it is a brain exam after death, this is possible.
2. There was a placebo effect.
3. There was a therapeutic effect better than placebo.
You are assuming #3 but we can't draw that conclusion yet. Even the authors of the study aren't claiming #3.
Would you call such a small sample as relevant?
May I ask what your interest in this is? Is there any relationship you should disclose?
Sustained treatment of symptoms is where the money is, cures are not. Putting patients on a maintenance drug regimen is longterm revenue stream.
> He has published about it and reverses Alzheimer in 9 out 10 patients and is currently doing new studies with a larger number of patients. TL;DR go to bed at 10 PM, do stress management, exercise a little, eat well and take supplements (blood tests determine which ones), and take a couple of other substances that our body needs, Alzheimer's disappears in less than 4 months.
Here is the study you reference, out of UCLA:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221920/
Interesting results, but it'd be great if someone reproduced that at a large scale.
On a similar note, you can cure type 2 diabetes in nearly any patient by putting them on a healthy diet of 800 calories a day for about 5 months, and then slowly growing their caloric intake back up to around 1500 a day (which is probably about the maximum necessary amount for most adult males in todays sedentary societal environment). This is well studied, proven, and reproducible, but telling people to not overeat and to avoid garbage food is not a particularly profitable endeavor.
https://www.thelancet.com/journals/lancet/article/PIIS0140-6...
Most people won't do those things, but will take a pill. Also, there's no need for a whole company to invent clean living or whatever, that's mostly the purview of TEDx talks and self-help authors.